|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1991)) |
IUPAC Name ![]() |
| ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5311 | flumazenil |
Synonyms ![]() |
| Anexate® |
| Ro15-1788 |
Database Links ![]() |
|
| CAS Registry No. | 78755-81-4 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL407 |
| DrugBank Ligand | DB01205 |
| PubChem CID | 3373 |
| Search Google for chemical match using the InChIKey | OFBIFZUFASYYRE-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | OFBIFZUFASYYRE |
| Search PubMed clinical trials | flumazenil |
| Search PubMed titles | flumazenil |
| Search PubMed titles/abstracts | flumazenil |
| Wikipedia | Flumazenil |
| Comments |
| Flumazenil reverses the effects of benzodiazepine sedatives. |